PD 124895

isolated from Streptomyces sp.; analog of PD 114721; structure given in first source

Also Known As:

PD-124895; kazusamycin B; 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-6-hydroxy-9-(hydroxymethyl)-3,5,7,11,15,17-hexamethyl-8-oxo-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - PD 124895: 2

Related Diseases

1.	Neoplasms (Cancer) 11/01/1987 - "Antitumor effect of kazusamycin B on experimental tumors."
2.	Lung Neoplasms (Lung Cancer) 11/01/1987 - "However, the activity of kazusamycin B toward L1210 or human lung cancer LX-1 was weaker. "
3.	Leukemia 06/01/1987 - "Kazusamycin B possesses potent cytocidal activities against L1210 (IC50 0.0018 micrograms/ml) and P388 (IC100 0.0016 micrograms/ml) leukemia cells in vitro."